Medicare’s cap on out-of-pocket costs helps cancer patients and others taking expensive drugs. With less financial burden, patients can better afford their medications.
FDA approval for the first brain stimulation device cleared for home use in treating depression
In this week’s edition of The Prototype we look at the biggest tech breakthroughs of 2025–and the year’s best music.
It isn’t wrong to promote healthier living. But misinforming the public on the flu vaccine and downplaying the disease’s impact aren’t in public health’s interest.
At least 12% of adults in the U.S. have been prescribed a glucagon‐like peptide‐1 drug for one or multiple indications, but 54% of users report affordability challenges.
As healthcare AI matures in 2026, proof beats promises, trust outperforms technology, and humans reclaim the center of care.
Significant changes to public health infrastructure, the healthcare system and economy in 2025 won’t end as we flip the calendar. Disruption will continue in 2026.
January 2026 marks a year since measles outbreaks began, which should prompt the Pan American Health Organization to revoke measles elimination status from the U.S.
Health insurance companies are expected to hold to their promises in 2026 to “streamline, simplify and reduce” prior authorization, the process of approving medical care.
A doctor explains what the latest research on alcohol teaches us about its effects on physical health and mental health; including how much alcohol is harmful for health.